{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:23:50Z","timestamp":1790745830601,"version":"4.1.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00800","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T06:21:07Z","timestamp":1589869267000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects"],"prefix":"10.3389","volume":"11","author":[{"given":"Andreea M.","family":"Bujor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"El Adili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshi","family":"Parvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Marden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Trojanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01702","article-title":"Innate immunity in systemic sclerosis fibrosis: recent advances.","volume":"9","author":"Laurent","year":"2018","journal-title":"Front Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.autrev.2010.09.016","article-title":"Fibrosis and immune dysregulation in systemic sclerosis.","volume":"10","author":"Chizzolini","year":"2011","journal-title":"Autoimmun Rev."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment.","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease.","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J Cell Physiol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis.","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthritis Res Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/labinvest.2010.73","article-title":"Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.","volume":"90","author":"Mathai","year":"2010","journal-title":"Lab Invest."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004005","article-title":"Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms.","volume":"11","author":"Mahoney","year":"2015","journal-title":"PLoS Comput Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ajpath.2011.11.024","article-title":"Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets.","volume":"180","author":"Greenblatt","year":"2012","journal-title":"Am J Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.biopha.2006.10.002","article-title":"SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice.","volume":"61","author":"Kimura","year":"2007","journal-title":"Biomed Pharmacother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jcp.21750","article-title":"Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis.","volume":"220","author":"Chujo","year":"2009","journal-title":"J Cell Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/art.11164","article-title":"Monocyte chemoattractant protein 3 as a mediator of fibrosis: overexpression in systemic sclerosis and the type 1 tight-skin mouse.","volume":"48","author":"Ong","year":"2003","journal-title":"Arthritis Rheum."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s13069-015-0028-7","article-title":"Enhanced chemokine-receptor expression, function, and signaling in healthy African American and scleroderma-patient monocytes are regulated by caveolin-1.","volume":"8","author":"Lee","year":"2015","journal-title":"Fibrogenesis Tissue Repair."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/1755-1536-4-15","article-title":"Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide.","volume":"4","author":"Tourkina","year":"2011","journal-title":"Fibrogenesis Tissue Repair."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1002\/art.21396","article-title":"Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation.","volume":"52","author":"Carulli","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1128\/mcb.20.15.5643-5652.2000","article-title":"Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor.","volume":"20","author":"Spyropoulos","year":"2000","journal-title":"Mol Cell Biol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3892\/ijo.9.1.9","article-title":"Expression of ets family of genes in systemic lupus erythematosus and Sjogren\u2019s syndrome.","volume":"9","author":"Georgiou","year":"1996","journal-title":"Int J Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0002-9440(10)63685-1","article-title":"Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.","volume":"163","author":"Kubo","year":"2003","journal-title":"Am J Pathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jdermsci.2010.06.008","article-title":"The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis.","volume":"59","author":"Asano","year":"2010","journal-title":"J Dermatol Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","article-title":"Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy.","volume":"176","author":"Asano","year":"2010","journal-title":"Am J Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/imm.12070","article-title":"The transcription factor Fli-1 regulates monocyte, macrophage and dendritic cell development in mice.","volume":"139","author":"Suzuki","year":"2013","journal-title":"Immunology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/exd.13724","article-title":"CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.","volume":"27","author":"Taniguchi","year":"2018","journal-title":"Exp Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1038\/jid.2008.39","article-title":"Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts.","volume":"128","author":"Bujor","year":"2008","journal-title":"J Invest Dermatol."},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1401s83","article-title":"The isolation and characterization of murine macrophages.","author":"Zhang","year":"2008","journal-title":"Curr Protoc Immunol."},{"key":"B24","first-page":"1530","article-title":"Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester.","volume":"42","author":"Tsuchiya","year":"1982","journal-title":"Cancer Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00403-004-0472-5","article-title":"Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.","volume":"296","author":"Hasegawa","year":"2004","journal-title":"Arch Dermatol Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/1523-1747.ep12276895","article-title":"Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma.","volume":"92","author":"Gay","year":"1989","journal-title":"J Invest Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis.","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin Liver Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41584-019-0212-z","article-title":"Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis.","volume":"15","author":"Kania","year":"2019","journal-title":"Nat Rev Rheumatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"L1046","DOI":"10.1152\/ajplung.00139.2012","article-title":"Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.","volume":"303","author":"Naik","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/art.21497","article-title":"Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells.","volume":"54","author":"Distler","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/1529-0131(200111)44:11<2665::aid-art446>3.0.co;2-s","article-title":"Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.","volume":"44","author":"Distler","year":"2001","journal-title":"Arthritis Rheum."},{"key":"B32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/rheumatology\/ken401","article-title":"Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis.","volume":"48","author":"Distler","year":"2009","journal-title":"Rheumatology."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aao3469","article-title":"Cadherin-11-mediated adhesion of macrophages to myofibroblasts establishes a profibrotic niche of active TGF-beta.","volume":"12","author":"Lodyga","year":"2019","journal-title":"Sci Signal."},{"key":"B34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s0923-1811(00)00169-9","article-title":"Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis.","volume":"26","author":"Yamamoto","year":"2001","journal-title":"J Dermatol Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.1365-2249.1999.00929.x","article-title":"Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.","volume":"117","author":"Hasegawa","year":"1999","journal-title":"Clin Exp Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/1529-0131(200106)44:6<1382::AID-ART231>3.0.CO;2-T","article-title":"Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression.","volume":"44","author":"Galindo","year":"2001","journal-title":"Arthritis Rheum."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1136\/annrheumdis-2018-213257","article-title":"Association of circulating CXCL10 and CXCL11 with systemic sclerosis.","volume":"77","author":"Crescioli","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.revmed.2009.05.001","article-title":"[Increase of CXCL10 serum level in systemic sclerosis interstitial pneumonia].","volume":"30","author":"Tiev","year":"2009","journal-title":"Rev Med Interne."},{"key":"B39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/rheumatology\/kem313","article-title":"CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis\u2013a longitudinal study.","volume":"47","author":"Antonelli","year":"2008","journal-title":"Rheumatology."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109763","article-title":"MMP-12 deficiency attenuates angiotensin II-induced vascular injury, M2 macrophage accumulation, and skin and heart fibrosis.","volume":"9","author":"Stawski","year":"2014","journal-title":"PLoS One."},{"key":"B41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.yjmcc.2019.04.007","article-title":"Matrix metalloproteinase-12 produced by Ly6C (low) macrophages prolongs the survival after myocardial infarction by preventing neutrophil influx.","volume":"131","author":"Kubota","year":"2019","journal-title":"J Mol Cell Cardiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.4049\/jimmunol.0903008","article-title":"Matrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosis.","volume":"184","author":"Madala","year":"2010","journal-title":"J Immunol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-3-2","article-title":"Macrophage metalloelastase (MMP-12) deficiency does not alter bleomycin-induced pulmonary fibrosis in mice.","volume":"3","author":"Manoury","year":"2006","journal-title":"J Inflamm."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1136\/annrheumdis-2011-200837","article-title":"Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.","volume":"71","author":"Manetti","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071362","article-title":"Ankyrin repeat domain 1 protein: a functionally pleiotropic protein with cardiac biomarker potential.","volume":"18","author":"Ling","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajpath.2014.09.018","article-title":"Global deletion of Ankrd1 results in a wound-healing phenotype associated with dermal fibroblast dysfunction.","volume":"185","author":"Samaras","year":"2015","journal-title":"Am J Pathol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0002-9440(10)62254-7","article-title":"CARP, a cardiac ankyrin repeat protein, is up-regulated during wound healing and induces angiogenesis in experimental granulation tissue.","volume":"166","author":"Shi","year":"2005","journal-title":"Am J Pathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1161\/01.res.88.1.30","article-title":"Transforming growth factor-beta\/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells.","volume":"88","author":"Kanai","year":"2001","journal-title":"Circ Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/rheumatology\/kei244","article-title":"Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients.","volume":"45","author":"Tan","year":"2006","journal-title":"Rheumatology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/art.27224","article-title":"Systemic sclerosis and lupus: points in an interferon-mediated continuum.","volume":"62","author":"Assassi","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/art.30318","article-title":"Interferon and alternative activation of monocyte\/macrophages in systemic sclerosis-associated pulmonary arterial hypertension.","volume":"63","author":"Christmann","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B52","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/art.38288","article-title":"Association of Interferon- and transforming growth factor beta-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis.","volume":"66","author":"Christmann","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.bbamem.2008.08.027","article-title":"Cytokine regulation of tight junctions.","volume":"1788","author":"Capaldo","year":"2009","journal-title":"Biochim Biophys Acta."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/jcp.24337","article-title":"Interferon-gamma promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)-1 and transforming growth factor (TGF) beta2.","volume":"228","author":"Chrobak","year":"2013","journal-title":"J Cell Physiol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00800\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T05:11:01Z","timestamp":1666588261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00800\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2020.00800"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00800","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"article-number":"800"}}